Activation of immune blood biomarkers from interferon gamma pathway distinguished long-term survivors (>=2 years) ...
MicuRx Pharmaceuticals, Inc. ("MicuRx"), a clinical-stage biopharmaceutical company focused on developing novel anti-infective therapies for drug-resistant bacterial infections, recently announced ...
The problem of antibiotic-resistant bacteria has many health experts worried. As disease-causing bacteria adapt to some of ...
Support in Riverview neighborhood for phasing out septic tanks hits mark for JEA to move ahead on $147 million project near ...
TOULOUSE, FRANCE AND BOSTON, MA / ACCESS Newswire / January 23, 2026 / Aviwell SAS, a deep‑tech animal nutrition ...
Space-based experiments show that microgravity-induced mutations in bacteriophages may improve their ability to target ...
Discover how a gingivectomy treats gum disease and improves aesthetics. Learn about the procedure, pain levels, and costs ...
Wockhardt announced that its novel intravenous antibiotic Foviscu (WCK 4282) has successfully met the primary endpoint in a Phase 3 clinical trial in patients with complicated urinary tract infections ...
2h
Vaxcyte Announces Commencement of Proposed Public Offering of Common Stock and Pre-Funded Warrants
BofA Securities, Jefferies, Leerink Partners, Evercore ISI and Guggenheim Securities are acting as joint book-running managers for the offering.
The zoo says a trial was carried out on a number of its Livingstone fruit bats prior to the rollout.
-- Dr. Mobasher held several executive roles in industry, most recently CMO at BeiGene -- IFLI contributed up to $9 million to Enterome's private funding round in 2025 -- Enterome has announced a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results